Biopack Environmental Solutions Inc. (OTCBB:BPAC), a designer, manufacturer, and supplier of 100% biodegradable and compostable packaging products, is pleased to announce it has entered into an agreement with Solupack Sistemas de Embalagens Ltda (“Solupack”) for distribution in Latin America. The distribution agreement will include the Latin American countries of Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay and Venezuela.
With their head office in Sao Paulo, Brazil, Solupack is an established distributor of many types of packaging products and machines throughout Latin America. They will use Biopack Environmental Solutions' products to launch into the biodegradable and environmentally friendly packaging market. Brazil is the world’s largest producer of sugarcane, and its related waste by-product called “Bagasse” which is the source of Biopack Environmental Solutions' products, but has few manufacturers of packaging products using this ingredient. Brazil uses most of this waste as an energy source by burning it.
Biopack Environmental Solutions manufactures 100% biodegradable consumer packaging products from locally available sugar cane waste called Bagasse. Based in Hong Kong with manufacturing facilities in Jiangmen, China, Biopack Environmental Solutions has earned the “premium brand” label in the biodegradable packaging market in Europe. Distributed under the “Roots Biopack” trademark, Biopack Environmental Solutions' unique line of compostable packaging is sold in 12 European countries, North America, Hong Kong, Taiwan and South Africa.
Celgene Corporation (NasdaqGS: CELG) revealed that Celgene has completed its acquisition of Abraxis BioScience, Inc. For each share of Abraxis common stock, Abraxis shareholders will receive (i) $58.00 in cash (ii) 0.2617 shares of Celgene common stock, and (iii) one tradeable Contingent Value Right (NYSEMKT:CVR), which entitles its holder to receive a pro rata share of potential payments for future regulatory milestones and commercial royalties.
Celgene Corporation discovers, develops, and commercializes innovative therapies to treat cancer and immune-inflammatory diseases in the United States, Europe, and internationally. Celgene's commercial stage products include REVLIMID for the treatment in combination with dexamethasone for multiple myeloma patients, as well as patients with transfusion-dependent anemia; and THALOMID to treat, in combination with dexamethasone, patients with newly diagnosed multiple myeloma, as well as for the prevention and suppression of cutaneous manifestations of erythema nodosum leprosum recurrence.
KLA-Tencor Corporation (NasdaqGS: KLAC), the world's leading supplier of process control and yield management solutions for the semiconductor and related industries, recently disclosed that KLA-Tencor will provide a live audio webcast of a conference call to review its first quarter fiscal year 2011 results on Thursday, October 28, 2010 at 2:00 p.m. PDT. The live webcast will be available on the Investor Relations page of KLA-Tencor's Web site at ir.kla-tencor.com/, and a replay of the webcast will remain available on KLA-Tencor's Investor Relations web page for twelve months following the conference call.
KLA-Tencor Corporation provides process control and yield management solutions for the semiconductor manufacturing and related microelectronics industries. KLA-Tencor offers equipment comprising patterned and unpatterned wafer inspection, defect review, and classification; reticle defect inspection; packaging and interconnect inspection; critical dimension metrology; pattern overlay metrology; film thickness, surface topography, and composition measurement; measurement of in-chamber process conditions, wafer shape, and stress metrology; computational lithography tools; and yield and fab-wide data management and analysis solutions.
CA Technologies (NasdaqGS: CA) reported a next-generation CA Automation Suite to help customers with their journey to a virtualized, dynamic cloud computing infrastructure. The Suite is designed to offer a comprehensive, business service-centric approach to the dynamic deployment and elastic scaling of IT infrastructure and services by automating, orchestrating, integrating and standardizing the provisioning and management of physical, virtual and cloud resources.
CA Technologies, together with its subsidiaries, engages in the design, development, marketing, licensing, and support of information technology (NYSE:IT) management software products that operate on a range of hardware platforms and operating systems. CA Technologies offers Enterprise IT Management software for organizations to manage IT computing environments, which include people, information, processes, systems, networks, and applications, as well as databases regardless of the hardware or software.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received $7,500.00, from a third party (Alan Jones Group) for two (2) days of advertising for Biopack Environmental Solutions, Inc. (OTC BB: BPAC.OB).